NOTA:FRA
Novartis AG
137,00 €
arrow_upward
+4,58%(+6,00) 1 p
24. juuli, 22:00:00 GMT +2 · EUR
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOTA põhistatistika genereerimine…
Ava
134,00 €
Kõrge
137,00 €
Madal
134,00 €
Turu kapit.
315,84 mld
Keskm. maht
12,00
Maht
30,00
52 näd kõrgeim
145,00 €
52 näd madalaim
95,20 €
Töötajate arv
75 tuh
Ava
134,00 €
Kõrge
137,00 €
Madal
134,00 €
Turu kapit.
315,84 mld
Keskm. maht
12,00
Maht
30,00
52 näd kõrgeim
145,00 €
52 näd madalaim
95,20 €
Töötajate arv
75 tuh
Uudised
Erinevatest veebiallikatest
AD HOC NEWS
·
4 tunni eest
Novartis stock trades steady as Cosentyx growth and eye-care spin-off shape outlook
Simply Wall Street
·
19 tunni eest
Revenue Beat: Novartis AG Beat Analyst Estimates By 5.7%
BioSpectrum Asia
·
1 päeva eest
Novartis to invest KRW 140 B in Korea’s radioligand therapy ecosystem
Seeking Alpha
·
2 päeva eest
Novartis Stock: The Buy Thesis Is Back (Rating Upgrade) (NYSE:NVS)
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud29. veebr 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com
AI genereeritud sisu võib sisaldada vigu. Lisateave